Allogene Therapeutics Inc
Open
SectorHealthcare
2.07 -6.33
Overview
Share price change
24h
Min
2.1
Max
2.23
Income | -3.8M -43M |
|---|---|
EPS | -0.18 |
Employees | 150 |
EBITDA | -91K -39M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +286.94% upside |
Next Earnings | 12 Aug 2026 |
|---|
Market Cap | -62M 725M |
|---|---|
Previous open | 8.4 |
Previous close | 2.07 |
News Sentiment
By Acuity
58%
42%
275 / 342 Healthcare
Allogene Therapeutics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Allogene Therapeutics Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 8.59 USD 286.94%
High 14 USD
Low 3.85 USD
Based on 13 Wall Street analysts offering 12 month price targets forAllogene Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$